XML 12 R4.htm IDEA: XBRL DOCUMENT v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 15,015 $ 2,825 $ 38,979 $ 10,788
Milestone liability change in fair value (411)   (1,165)  
General and administrative 6,863 4,049 20,320 12,913
Total operating expenses 21,467 6,874 58,134 23,701
Loss from operations (21,467) (6,874) (58,134) (23,701)
Other income, net 303 263 1,335 981
Sermonix pre-funded warrant change in fair value 0   (16,320)  
Net loss (21,164) (6,611) (73,119) (22,720)
Unrealized (loss) gain on available-for-sale securities (3) 1 (8) (3)
Comprehensive loss attributable to common stockholders $ (21,167) $ (6,610) $ (73,127) $ (22,723)
Net loss per share attributable to common stockholders, basic $ (0.89) $ (1.68) $ (3.30) $ (5.8)
Net loss per share attributable to common stockholders, diluted $ (0.89) $ (1.68) $ (3.30) $ (5.8)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic 23,740,719 3,943,887 22,181,938 3,919,258
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted 23,740,719 3,943,887 22,181,938 3,919,258